Status:
UNKNOWN
Pharmacist-led Interventions to Improve Medication Use
Lead Sponsor:
Tabula Rasa HealthCare
Conditions:
Pharmacogenomics
Old Age
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this project is to stimulate identification and report of patient's medical story for whom their clinical conditions beneficiated from pharmacists' interventions based on a medication...
Detailed Description
METHODS TRHC aims to collect data about participants using direct or retrospective observations such as patient's demographics, medical lab tests, clinical decision support systems, and examination of...
Eligibility Criteria
Inclusion
- Patients meeting all the following criteria will be considered:
- Patient enrolled in a healthcare organization where TRHC provides pharmacy services during the implementation period.
- Patient (or legal representative) able to understand, and provide informed consent to publish his/her case story.
- Patient's case will provide generalizable knowledge to the existing literature based on direct observation, interview, benign behavioral intervention, or findings from drug regimen or drugs claims data.
Exclusion
- Patients with one of the following criteria will be excluded:
- a) Patient's refusal to participate in a case study
Key Trial Info
Start Date :
January 25 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 24 2024
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT05346770
Start Date
January 25 2022
End Date
July 24 2024
Last Update
September 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute
Orlando, Florida, United States, 32827